Article
Family-based and case-control studies reveal no association of lipocalin-type prostaglandin D2 synthase with schizophrenia.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics - 5 Jul 2007
Ruano Dina, Macedo António, Soares Maria João, Valente José, Azevedo Maria Helena, Pato Carlos, Hutz Mara Helena, Gama Clarissa S, Lobato Maria Inês, Belmonte-de-Abreu Paulo, Heutink Peter, Palha Joana Almeida
Abstract excerpt
Several observations point to the involvement of disturbed lipid biology in schizophrenia. Reduced response to niacin flushing test, which involves vasodilatation induced by prostaglandin D2 (PGD2), is among the evidences, together with decreased CSF levels of lipocalin-type prostaglandin D2 synthase (PTGDS), the enzyme responsible for the synthesis of PGD2 in the brain. Since PTGDS is also a carrier for...
Topics
- Alleles
- Brazil
- Case-Control Studies
- Family
- Female
- Genetic Predisposition to Disease
- Genotype
- Haplotypes
- Humans
